CS logo
small CS logo
Clínica Universidad de Navarra

Madrid, Spain
University hospital in Madrid
C. Marquesado de Sta. Marta, 1, 28027 Madrid

About Clínica Universidad de Navarra


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Clinica Universidad de Navarra, Universidad de Navarra
5
Grupo Español de Investigación en Cáncer de Ovario
4
Hoffmann-La Roche
4
Celgene
3
Eli Lilly and Company
3
Anthos Therapeutics, Inc.
2
Astex Pharmaceuticals, Inc.
2
BeiGene
2
BioNTech SE
2
Daiichi Sankyo, Inc.
2
Eidos Therapeutics, a BridgeBio company
2
Total Rows: 64

Clinical Trials at Clínica Universidad de Navarra


During the past decade, Clínica Universidad de Navarra conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 3 clinical trials were completed, i.e. on average, 3.7% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 2 clinical trials were completed. i.e. 4.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years55882121222216161010000011111100Started TrialsCompleted Trails2017201820192020202120220102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Outcomes Study Using a New Implantable Neurostimulation System for Chronic Intractable Pain
2012-08-01
2014-12-01
Completed
40
Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma
2018-05-28
2025-10-01
Recruiting
200
This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer.
2017-05-04
2023-08-24
Active, not recruiting
133
Study of AGEN2034 in Advanced Tumors and Cervical Cancer
2017-04-11
2022-06-15
Completed
211
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
2017-04-03
2018-12-01
Unknown status
172
Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer
2018-05-30
2021-08-26
Completed
48
Study of ASTX727 vs IV Decitabine in MDS, CMML, and AML
2018-02-15
2023-03-31
Active, not recruiting
200
Second-generation Drug-eluting Stents in Diabetes
2017-12-19
2022-01-28
Unknown status
1,164

Rows per page:

1–85 of 85

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Clínica Universidad de Navarra" #1 sponsor was "Clinica Universidad de Navarra, Universidad de Navarra" with 5 trials, followed by "Grupo Español de Investigación en Cáncer de Ovario" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 64 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Clínica Universidad de Navarra" #1 collaborator was "AKRN Scientific Consulting, S.L." with 2 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Itreas" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 48 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Clínica Universidad de Navarra


According to Clinical.Site data, the most researched conditions in "Clínica Universidad de Navarra" are "Pulmonary Embolism" (5 trials), "Fallopian Tube Cancer" (4 trials), "Advanced Cancer" (3 trials), "Breast Cancer" (3 trials) and "Cervical Cancer" (3 trials). Many other conditions were trialed in "Clínica Universidad de Navarra" in a lesser frequency.

Clinical Trials Intervention Types at Clínica Universidad de Navarra


Most popular intervention types in "Clínica Universidad de Navarra" are "Drug" (70 trials), "Biological" (7 trials), "Device" (5 trials), "Other" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Pembrolizumab" (5 trials), "Atezolizumab" (4 trials), "Carboplatin" (4 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Clínica Universidad de Navarra


The vast majority of trials in "Clínica Universidad de Navarra" are 71 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Clínica Universidad de Navarra


Currently, there are 60 active trials in "Clínica Universidad de Navarra". 2 are not yet recruiting, 33 are recruiting, 24 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in Clínica Universidad de Navarra, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Clínica Universidad de Navarra, 20 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status